1 Day
Source:
تونزي تيليغراف
Central Pharmacy confirms small price increases
The rise in the prices of some imported medicines in Tunisia has sparked wide controversy, following a clarification from a source at the Central Pharmacy stating that the issue relates to a limited review of prices for certain items that had not been updated for years. The increase was limited to a few Tunisian dinars or millimes due to rising import costs and global prices. Experts confirmed that, despite its limited scope, these increases raise broader questions about Tunisia's pharmaceutical system's ability to face a financial and structural crisis threatening the continued availability of essential medicines, especially for patients with chronic illnesses or retirees. They pointed out that the problems go beyond pricing to encompass financing difficulties, low stock levels, and challenges in securing the country's need for hard currency. They emphasized the necessity of a comprehensive reform of the system to support local industry and ensure citizens' right to healthcare without additional burdens.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)